Novus Therapeutics, Inc. 4
4 · Novus Therapeutics, Inc. · Filed Jul 5, 2017
Insider Transaction Report
Form 4
McBride John S.
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-06-30+18,000→ 18,000 totalExercise: $5.85Exp: 2027-06-30→ Common Stock (18,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 18,000 shares of the Issuer's Common Stock. The shares will vest ratably each quarter over three years beginning on June 30, 2017.